Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
31.61
-0.06 (-0.19%)
At close: Nov 13, 2026, 4:00 PM EST
30.98
-0.63 (-1.99%)
After-hours: Nov 13, 2026, 4:37 PM EST
Surrozen Revenue
Surrozen had revenue of $10.53M in the twelve months ending September 30, 2026, up 192.12% year-over-year. In the year 2025, Surrozen had annual revenue of $3.48M, down -67.37%. That makes Surrozen the 37,153rd largest company in the world by revenue and 4,856th in the United States.
Revenue (ttm)
$10.53M
Revenue Growth
+192.12%
P/S Ratio
56.23
Revenue / Employee
$239,273
Employees
44
Market Cap
602.54M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.48M | -7.18M | -67.37% |
| Dec 31, 2024 | 10.66M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 12.50M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Geron | 217.52M |
| Arbutus Biopharma | 181.49M |
| Valneva SE | 163.30M |
| REGENXBIO | 153.91M |
| Ginkgo Bioworks Holdings | 130.75M |
| Wave Life Sciences | 70.92M |
| Crescent Biopharma | 11.88M |
| Capricor Therapeutics | 11.13M |
SRZN News
- 10 hours ago - Surrozen prices 1.89M shares of common stock at $31.67 - TheFly
- 10 hours ago - Surrozen Announces Pricing of $60 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 1 day ago - Surrozen price target raised to $80 from $42 at Guggenheim - TheFly
- 3 days ago - Surrozen Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 3 days ago - Surrozen reports Q3 EPS ($11.02) vs. ($8.36) last eyar - TheFly
- 3 days ago - Surrozen price target raised to $62 from $40 at Cantor Fitzgerald - TheFly
- 4 days ago - Surrozen Reports Third Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 4 days ago - Surrozen Earnings release: Q3 2026 - Filings